Date: September 02, 2026

Financial Results (Standalone)

FY2026 Performance:

  • Operating Revenue: ₹87,534 lakhs (29% increase from FY2025 ₹67,830 lakhs)
  • Other Income: ₹2,689 lakhs (vs. ₹1,425 lakhs in FY2025)
  • EBITDA: ₹8,158 lakhs (52% increase from FY2025 ₹5,358 lakhs)
  • EBITDA Margin: 9.3% (vs. 7.9% in FY2025)
  • Finance Cost: ₹1,945 lakhs (vs. ₹1,607 lakhs in FY2025)
  • EBTDA: ₹6,213 lakhs (66% increase from FY2025 ₹3,751 lakhs)
  • Depreciation: ₹2,281 lakhs (vs. ₹1,997 lakhs in FY2025)
  • EBT & Exceptional Item: ₹3,931 lakhs (vs. ₹1,754 lakhs in FY2025)
  • Exceptional Item: ₹1,064 lakhs (non-cash impairment loss of investments in APAG Holding AG)
  • EBT from Continuing Operations: ₹2,867 lakhs (vs. loss of ₹2,745 lakhs in FY2025)
  • Tax: Negative ₹574 lakhs (due to reversal of Deferred Tax by ₹2,143 lakhs under 'New Tax Regime')
  • Profit from Continuing Operations: ₹3,441 lakhs (vs. loss of ₹3,888 lakhs in FY2025)
  • Profit from Discontinued Operations: Nil (vs. ₹90 lakhs in FY2025)
  • Net Profit: ₹3,441 lakhs (vs. net loss of ₹3,798 lakhs in FY2025)
  • Other Comprehensive Income (OCI): ₹252 lakhs (vs. negative ₹7 lakhs in FY2025)
  • Total Comprehensive Income (TCI): ₹3,693 lakhs (vs. negative ₹3,805 lakhs in FY2025)
  • EPS: ₹7.88 (vs. negative ₹8.69 in FY2025)

Kenya Subsidiary Performance

FY2026 Performance:

  • Operating Revenue: ₹10,608 lakhs (40% increase from FY2025 ₹7,601 lakhs)
  • Other Income: ₹259 lakhs (vs. ₹797 lakhs in FY2025)
  • EBITDA: ₹1,925 lakhs (14x increase from FY2025 ₹128 lakhs)
  • EBITDA Margin: 18.1% (vs. 1.7% in FY2025)
  • Finance Cost: ₹1,956 lakhs (vs. ₹2,049 lakhs in FY2025)
  • EBTDA: Negative ₹31 lakhs (vs. negative ₹1,921 lakhs in FY2025)
  • Depreciation: ₹1,236 lakhs (vs. ₹1,194 lakhs in FY2025)
  • EBT: Negative ₹1,267 lakhs (vs. negative ₹3,115 lakhs in FY2025)

Consolidated Profitability

FY2026 Performance:

  • Operating Revenue increased by 30%
  • EBITDA increased by 90%
  • APAG Holding AG, Switzerland ceased to be subsidiary during the year
  • Finance Cost: ₹3,197 lakhs (vs. ₹3,106 lakhs in FY2025)
  • EBTDA: ₹6,182 lakhs (vs. ₹1,830 lakhs in FY2025)
  • Depreciation: ₹3,517 lakhs (vs. ₹3,191 lakhs in FY2025)
  • EBT & Exceptional Item: ₹2,665 lakhs (vs. negative ₹1,361 lakhs in FY2025)
  • Exceptional Item: Nil (vs. ₹2,944 lakhs in FY2025)
  • EBT from Continuing Operations: ₹2,665 lakhs (vs. negative ₹4,306 lakhs in FY2025)
  • Tax: Negative ₹574 lakhs (vs. ₹1,143 lakhs in FY2025)
  • Profit from Continuing Operations: ₹3,239 lakhs (vs. negative ₹5,449 lakhs in FY2025)
  • Profit from Discontinued Operations: ₹8,081 lakhs (includes Gain on Loss of Control of ₹9,765 lakhs; vs. negative ₹5,366 lakhs in FY2025)
  • Net Profit: ₹11,319 lakhs (vs. negative ₹10,815 lakhs in FY2025)
  • Other Comprehensive Income: ₹808 lakhs (vs. not specified in FY2025)

Future Outlook

Corporate Strategy:

  • 'Vision 2030' roadmap aimed at sustainable growth and improved profitability underway
  • Favourable business prospects with increasing industrial activity and growing customer demand
  • Triacetin and Penta Derivatives expected to perform well
  • Projects involving diversification in specialty chemicals to be commissioned shortly
  • Actively pursuing capacity addition in Formaldehyde and Resin
  • Continuing thrust on programs involving process and supply chain improvement and cost reduction
  • Threat from geopolitical situation and high tariffs

Promoter Funding:

  • Promoters contributing ₹49.5 crores through 7% NCRPS

Ethiopian Operations (KAT):

  • Backed by liberalization measures announced by Ethiopian Government
  • Expected to continue delivering improved performance
  • Evaluating addition in weaving capacity; incremental Capex will be moderate due to surplus capacity in other departments
  • Exposed to threat from currency volatility, inflation, and changes in Government policy in Ethiopia

Disclaimer

The presentation contains forward-looking statements that involve risks, uncertainties and other factors that could cause actual results to differ from projections. The company undertakes no obligation to update forward-looking statements.